Brachyspira and Intestinal Allergy-like Immune Reactions in Patients With Irritable Bowel Syndrome (IBS)

Recruiting N/A Interventional Study
Irritable Bowel Syndrome Food Sensitivity
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
200 (estimated)
Sponsor
Magnus Simrén · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this study is to define local immune responses in the GI tract to food antigens in IBS patients, with and without Brachyspira infection, using advanced imaging. We hypothesize that Brachyspira infection can cause IBS symptoms by inducing loss of oral tolerance to dietary antigens through development of food-specific intestinal immune reactions and subsequent development of visceral hype…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with IBS diagnosis according to their treating physician (ROME IV). * Association between intake of food and GI symptoms. * Witnessed written informed consent prior to any study procedures. * Patients who are capable to understand the study and the questionnaires, and…
Contacts

Magnus Simrén, MD PhD

0046313428107

magnus.simren@medicine.gu.se

CONTACT

MagTarmlab office

0046313428107

magtarmlab.su@vgregion.se

CONTACT